Protara Therapeutics, Inc.
What this means
- Net loss in 2025Net loss of $57.4M for the year (2024: −$44.6M).
What to do next
- How to check a US company before you sign a contractguide
- How to read an 8-K: what customers and creditors should checkguide
Guides from the Companies Daily newsroom, picked for what the register shows.
Financials from XBRL
| Calendar-year frame | 2025 | 2024 |
|---|---|---|
| Net income (loss) | −$57.4M | −$44.6M |
| Total assets | $209M | $181M |
| Total liabilities | $13.1M | $14.3M |
| Stockholders’ equity | $196M | $167M |
| Cash and equivalents | $49.7M | $163M |
From XBRL data the company filed with the SEC (data.sec.gov frames, US GAAP, US dollars). A frame aligns the fiscal year with the calendar year closest to it; this company’s fiscal year ends December 31. Check the annual report for the exact figures and periods.
- Name as filed
- Protara Therapeutics, Inc.
Formerly: Protara Therapeutics, Inc. - CIK
- 0001359931
- Tickers
- TARA
- Kind of filer
- SEC-reporting company
Non-accelerated filer; Smaller reporting company - Status
- Filing with the SEC
- State of incorporation
- —
- Industry (SIC)
- 2836 · Biological products, (no diagnostic substances)
Industry: D · Manufacturing → - Fiscal year ends
- December 31
- Last annual report
- 10-K for the period ended Dec 31, 2025
- Last quarterly report
- 10-Q for the quarter ended Sep 30, 2026
- Bankruptcy reported
- Not in our data
- Last edition event
- Nov 6, 2026
Filing history
Newest first: the filings we classify (8-K items, late filing notices, delistings, deregistration, IPO registrations, Schedule 13D, Form D, annual and quarterly reports), from Jan 1, 2023. All documents, including those we do not classify, are in the EDGAR filing index.
- Form 10-Q · filed Nov 6, 2026 · filing
- Form 8-K · items 2.02, 9.01 · filed Nov 6, 2026 · filing · edition of Nov 6, 2026
- Form 8-K · items 2.02, 9.01 · filed Aug 11, 2026 · filing
- Form 10-Q · filed Aug 11, 2026 · filing
- Form 8-K · items 5.02 · filed Jun 29, 2026 · filing
- Form 8-K · items 2.02, 9.01 · filed May 13, 2026 · filing
- Form 10-Q · filed May 13, 2026 · filing
- Form 8-K · items 2.02, 9.01 · filed Mar 10, 2026 · filing
- Form 10-K · filed Mar 10, 2026 · filing
- Form 8-K · items 2.02, 9.01 · filed Nov 10, 2025 · filing
- Form 10-Q · filed Nov 10, 2025 · filing
- Form 8-K · items 2.02, 9.01 · filed Aug 11, 2025 · filing
- Form 10-Q · filed Aug 11, 2025 · filing
- Form 8-K · items 2.02, 9.01 · filed May 8, 2025 · filing
- Form 10-Q · filed May 8, 2025 · filing
- Form 8-K · items 2.02, 9.01 · filed Mar 5, 2025 · filing
- Form 10-K · filed Mar 5, 2025 · filing
- Form 8-K · items 2.02, 9.01 · filed Nov 12, 2024 · filing
- Form 10-Q · filed Nov 12, 2024 · filing
- Form 8-K · items 2.02, 9.01 · filed Aug 6, 2024 · filing
- Form 10-Q · filed Aug 6, 2024 · filing
- Form 8-K · items 2.02, 9.01 · filed May 2, 2024 · filing
- Form 10-Q · filed May 2, 2024 · filing
- Form 8-K · items 5.02, 9.01 · filed Mar 18, 2024 · filing
- Form 8-K · items 2.02, 9.01 · filed Mar 13, 2024 · filing
- Form 10-K · filed Mar 13, 2024 · filing
- Form 8-K · items 2.02, 9.01 · filed Nov 3, 2023 · filing
- Form 10-Q · filed Nov 3, 2023 · filing
- Form 8-K · items 2.02, 9.01 · filed Aug 3, 2023 · filing
- Form 10-Q · filed Aug 3, 2023 · filing
- Form 8-K · items 2.02, 9.01 · filed May 4, 2023 · filing
- Form 10-Q · filed May 4, 2023 · filing
- Form 8-K · items 2.02, 9.01 · filed Mar 8, 2023 · filing
- Form 10-K · filed Mar 8, 2023 · filing
- Form 8-K · items 5.02, 7.01, 9.01 · filed Jan 30, 2023 · filing